Improvement in pulmonary function following antibiotics in infants with cystic fibrosis

Jessica E. Pittman, Robin C. Johnson, Stephanie Davis

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Recent studies have shown the presence of lung disease in even asymptomatic infants with cystic fibrosis (CF). While pulmonary function testing (PFT) is often used to follow progression of lung disease and guide treatment in older children with CF, little data is available on change in infant PFTs in young children with CF. Objective: To determine change in infant PFTs before and after antibiotic therapy for pulmonary exacerbation in infants with CF. Methods: Retrospective cohort study of infants with CF who underwent clinically indicated infant PFTs before and after antibiotic therapy for CF pulmonary exacerbation at the University of North Carolina at Chapel Hill. Results: Pre- and post-antibiotics PFT data was available on 11 infants with CF, with a mean age of 102 weeks at time of first PFT. The majority of infants were symptomatic prior to antibiotics, and showed statistically significant improvement in clinical parameters following treatment. Prior to antibiotics, PFTs showed evidence of substantial obstructive disease (mean z-scores for FVC, FEV 0.5, and FEF 25-75 of -1.81, -3.06, and -4.5, respectively) and air-trapping/hyperinflation (mean z-scores for FRCpleth, RV, and RV/TLC of 8.86, 7.1, and 3.31, respectively). Following antibiotics, all of the above parameters showed statistically significant improvement. Discussion: We have shown a statistically significant improvement in infant PFT measures following antibiotic therapy in a cohort of 11 infants with CF, which paralleled improvement in clinical parameters. Though infant PFTs showed improvement, they remained abnormal in the majority of subjects, with persistent airtrapping and hyperinflation after antibiotic therapy. Our findings suggest that infant PFTs are sensitive to acute clinical changes in children with CF, and may be a useful tool in managing infants with CF.

Original languageEnglish (US)
Pages (from-to)441-446
Number of pages6
JournalPediatric Pulmonology
Volume47
Issue number5
DOIs
StatePublished - May 2012
Externally publishedYes

Fingerprint

Cystic Fibrosis
Anti-Bacterial Agents
Lung
Lung Diseases
Therapeutics
Cohort Studies
Retrospective Studies
Air

Keywords

  • Cystic fibrosis
  • Infant
  • Pulmonary cystic fibrosis
  • Respiratory function tests

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Improvement in pulmonary function following antibiotics in infants with cystic fibrosis. / Pittman, Jessica E.; Johnson, Robin C.; Davis, Stephanie.

In: Pediatric Pulmonology, Vol. 47, No. 5, 05.2012, p. 441-446.

Research output: Contribution to journalArticle

Pittman, Jessica E. ; Johnson, Robin C. ; Davis, Stephanie. / Improvement in pulmonary function following antibiotics in infants with cystic fibrosis. In: Pediatric Pulmonology. 2012 ; Vol. 47, No. 5. pp. 441-446.
@article{42df90b53d344490abcb2bd54480feca,
title = "Improvement in pulmonary function following antibiotics in infants with cystic fibrosis",
abstract = "Background: Recent studies have shown the presence of lung disease in even asymptomatic infants with cystic fibrosis (CF). While pulmonary function testing (PFT) is often used to follow progression of lung disease and guide treatment in older children with CF, little data is available on change in infant PFTs in young children with CF. Objective: To determine change in infant PFTs before and after antibiotic therapy for pulmonary exacerbation in infants with CF. Methods: Retrospective cohort study of infants with CF who underwent clinically indicated infant PFTs before and after antibiotic therapy for CF pulmonary exacerbation at the University of North Carolina at Chapel Hill. Results: Pre- and post-antibiotics PFT data was available on 11 infants with CF, with a mean age of 102 weeks at time of first PFT. The majority of infants were symptomatic prior to antibiotics, and showed statistically significant improvement in clinical parameters following treatment. Prior to antibiotics, PFTs showed evidence of substantial obstructive disease (mean z-scores for FVC, FEV 0.5, and FEF 25-75 of -1.81, -3.06, and -4.5, respectively) and air-trapping/hyperinflation (mean z-scores for FRCpleth, RV, and RV/TLC of 8.86, 7.1, and 3.31, respectively). Following antibiotics, all of the above parameters showed statistically significant improvement. Discussion: We have shown a statistically significant improvement in infant PFT measures following antibiotic therapy in a cohort of 11 infants with CF, which paralleled improvement in clinical parameters. Though infant PFTs showed improvement, they remained abnormal in the majority of subjects, with persistent airtrapping and hyperinflation after antibiotic therapy. Our findings suggest that infant PFTs are sensitive to acute clinical changes in children with CF, and may be a useful tool in managing infants with CF.",
keywords = "Cystic fibrosis, Infant, Pulmonary cystic fibrosis, Respiratory function tests",
author = "Pittman, {Jessica E.} and Johnson, {Robin C.} and Stephanie Davis",
year = "2012",
month = "5",
doi = "10.1002/ppul.21575",
language = "English (US)",
volume = "47",
pages = "441--446",
journal = "Pediatric Pulmonology",
issn = "8755-6863",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Improvement in pulmonary function following antibiotics in infants with cystic fibrosis

AU - Pittman, Jessica E.

AU - Johnson, Robin C.

AU - Davis, Stephanie

PY - 2012/5

Y1 - 2012/5

N2 - Background: Recent studies have shown the presence of lung disease in even asymptomatic infants with cystic fibrosis (CF). While pulmonary function testing (PFT) is often used to follow progression of lung disease and guide treatment in older children with CF, little data is available on change in infant PFTs in young children with CF. Objective: To determine change in infant PFTs before and after antibiotic therapy for pulmonary exacerbation in infants with CF. Methods: Retrospective cohort study of infants with CF who underwent clinically indicated infant PFTs before and after antibiotic therapy for CF pulmonary exacerbation at the University of North Carolina at Chapel Hill. Results: Pre- and post-antibiotics PFT data was available on 11 infants with CF, with a mean age of 102 weeks at time of first PFT. The majority of infants were symptomatic prior to antibiotics, and showed statistically significant improvement in clinical parameters following treatment. Prior to antibiotics, PFTs showed evidence of substantial obstructive disease (mean z-scores for FVC, FEV 0.5, and FEF 25-75 of -1.81, -3.06, and -4.5, respectively) and air-trapping/hyperinflation (mean z-scores for FRCpleth, RV, and RV/TLC of 8.86, 7.1, and 3.31, respectively). Following antibiotics, all of the above parameters showed statistically significant improvement. Discussion: We have shown a statistically significant improvement in infant PFT measures following antibiotic therapy in a cohort of 11 infants with CF, which paralleled improvement in clinical parameters. Though infant PFTs showed improvement, they remained abnormal in the majority of subjects, with persistent airtrapping and hyperinflation after antibiotic therapy. Our findings suggest that infant PFTs are sensitive to acute clinical changes in children with CF, and may be a useful tool in managing infants with CF.

AB - Background: Recent studies have shown the presence of lung disease in even asymptomatic infants with cystic fibrosis (CF). While pulmonary function testing (PFT) is often used to follow progression of lung disease and guide treatment in older children with CF, little data is available on change in infant PFTs in young children with CF. Objective: To determine change in infant PFTs before and after antibiotic therapy for pulmonary exacerbation in infants with CF. Methods: Retrospective cohort study of infants with CF who underwent clinically indicated infant PFTs before and after antibiotic therapy for CF pulmonary exacerbation at the University of North Carolina at Chapel Hill. Results: Pre- and post-antibiotics PFT data was available on 11 infants with CF, with a mean age of 102 weeks at time of first PFT. The majority of infants were symptomatic prior to antibiotics, and showed statistically significant improvement in clinical parameters following treatment. Prior to antibiotics, PFTs showed evidence of substantial obstructive disease (mean z-scores for FVC, FEV 0.5, and FEF 25-75 of -1.81, -3.06, and -4.5, respectively) and air-trapping/hyperinflation (mean z-scores for FRCpleth, RV, and RV/TLC of 8.86, 7.1, and 3.31, respectively). Following antibiotics, all of the above parameters showed statistically significant improvement. Discussion: We have shown a statistically significant improvement in infant PFT measures following antibiotic therapy in a cohort of 11 infants with CF, which paralleled improvement in clinical parameters. Though infant PFTs showed improvement, they remained abnormal in the majority of subjects, with persistent airtrapping and hyperinflation after antibiotic therapy. Our findings suggest that infant PFTs are sensitive to acute clinical changes in children with CF, and may be a useful tool in managing infants with CF.

KW - Cystic fibrosis

KW - Infant

KW - Pulmonary cystic fibrosis

KW - Respiratory function tests

UR - http://www.scopus.com/inward/record.url?scp=84859823106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859823106&partnerID=8YFLogxK

U2 - 10.1002/ppul.21575

DO - 10.1002/ppul.21575

M3 - Article

C2 - 22009796

AN - SCOPUS:84859823106

VL - 47

SP - 441

EP - 446

JO - Pediatric Pulmonology

JF - Pediatric Pulmonology

SN - 8755-6863

IS - 5

ER -